• Mashup Score: 2
    Stock.us - 3 year(s) ago

    Symbol/NameCompanySectorMarketFundFilingsResearchToolsSign In  Sign Up

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      Chinese vaccine maker CanSino Biologics Inc (CanSinoBIO) (https://t.co/7o9q8r9daw) said on Friday it had returned to operating profit of 802.3 million yuan ($123.79 million) in the first six months of 2021, driven by use of its COVID-19 shot. https://t.co/GlRLBYb4Jm

  • Mashup Score: 0
    CanSinoBIO - 6185.HK - Company Analysis HKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 18/S18/A19/S19/A20/S20Q320/A21Q1DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      China's CanSino Biologics (https://t.co/7o9q8r9daw), (CanSinoBIO) may start as early as next month a clinical trial using Russia's Sputnik V vaccine followed by a shot of its own COVID-19 vaccine, a senior executive said late on Thursday. https://t.co/XoAyp0rvjQ

  • Mashup Score: 2
    CanSinoBIO - 6185.HK - Company Analysis HKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 18/S18/A19/S19/A20/S20Q320/A21Q1DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      China's CanSino Biologics (https://t.co/7o9q8r9daw), (CanSinoBIO) may start as early as next month a clinical trial using Russia's Sputnik V vaccine followed by a shot of its own COVID-19 vaccine, a senior executive said late on Thursday. https://t.co/h1Y7MCWLDt

  • Mashup Score: 1
    CanSinoBIO - 6185.HK - Company Analysis HKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 18/S18/A19/S19/A20/S20Q320/A21Q1DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      China's CanSino Biologics (https://t.co/7o9q8r9daw), (CanSinoBIO) may start as early as next month a clinical trial using Russia's Sputnik V vaccine followed by a shot of its own COVID-19 vaccine, a senior executive said late on Thursday. https://t.co/keQdwFjAhe

  • Mashup Score: 6
    CanSinoBIO - 6185.HK - Company Analysis HKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 18/S18/A19/S19/A20/S20Q320/A21Q1DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      An inhaled version of CanSino Biologics' (https://t.co/7o9q8r9daw), (CanSinoBIO) COVID-19 vaccine triggered immune responses without serious side effects, an early-stage clinical trial showed. https://t.co/JLTvCHotUO

  • Mashup Score: 5
    CanSinoBIO - 6185.HK - Company Analysis HKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 18/S18/A19/S19/A20/S20Q320/A21Q1DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      An inhaled version of CanSino Biologics' (https://t.co/7o9q8r9daw), (CanSinoBIO) COVID-19 vaccine triggered immune responses without serious side effects, an early-stage clinical trial showed. https://t.co/DGnLUIgXDa

  • Mashup Score: 1
    CanSinoBIO - 6185.HK - Company Analysis HKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 18/S18/A19/S19/A20/S20Q320/A21Q1DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      An inhaled version of CanSino Biologics' (https://t.co/7o9q8r9daw), (CanSinoBIO) COVID-19 vaccine triggered immune responses without serious side effects, an early-stage clinical trial showed. https://t.co/qICm52LyjR

  • Mashup Score: 2
    Sinopharm - 1099.HK - Company AnalysisHKG:1099 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price23.3 39.5 /14.9 P/E8 17.2 /6.38 P/B1.06 2.54 /0.87 P/S0.13 0.31 /0.1 P/CF-11 35 /-598.4 EV/EBIT0.09 0.21 /0.06 EV/EBITDA0.09 0.21 /0.06 P/B(tang.)1.31 3.11 /1.04 DirectorHeadcount23 pplIndependent Director0 pplAge (mean)54.8Doctors4 pplMasters11 pplQuits LTM3 pplQuits L3Y12 pplExecutiveHeadcount12 pplAge (mean)52Doctors1 pplMasters3 pplQuits LTM0Quits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      Moroccan pharmaceutical firm Sothema (SOT.CS) will soon start production of 5 million doses a month of China's Sinopharm (https://t.co/O6fP1m2YZn) COVID-19 vaccine in the North African country, state news agency MAP reported on Monday. https://t.co/PuON5Ded7S

  • Mashup Score: 1
    Sinopharm - 1099.HK - Company AnalysisHKG:1099 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price23.3 39.5 /14.9 P/E8 17.2 /6.38 P/B1.06 2.54 /0.87 P/S0.13 0.31 /0.1 P/CF-11 35 /-598.4 EV/EBIT0.09 0.21 /0.06 EV/EBITDA0.09 0.21 /0.06 P/B(tang.)1.31 3.11 /1.04 DirectorHeadcount23 pplIndependent Director0 pplAge (mean)54.8Doctors4 pplMasters11 pplQuits LTM3 pplQuits L3Y12 pplExecutiveHeadcount12 pplAge (mean)52Doctors1 pplMasters3 pplQuits LTM0Quits…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      Moroccan pharmaceutical firm Sothema (SOT.CS) will soon start production of 5 million doses a month of China's Sinopharm (https://t.co/O6fP1m2YZn) COVID-19 vaccine in the North African country, state news agency MAP reported on Monday. https://t.co/VuPjzganvI

  • Mashup Score: 0
    CanSinoBIO - 6185.HK - Company AnalysisHKG:6185 - 3 year(s) ago

    CurrentHigh/LowPCTL(by Days)Price421.6 434.2 /30.1 P/E-221.4 -39.5 /-516.5 P/B14.6 40.8 /3.91 P/S4,735 20,906 /3,008 EV/EBIT-168.7 -28.9 /-357.1 EV/EBITDA-168.7 -30 /-357.1 P/B(tang.)14.6 41.9 /3.99 DirectorHeadcount16 pplIndependent Director0 pplAge (mean)51.1Doctors5 pplMasters10 pplQuits LTM0 pplQuits L3Y3 pplExecutiveHeadcount9 pplAge (mean)57Doctors9 pplQuits LTM0Quits L3Y0 CompanyCanSino…

    Source: stock.us
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Reuters_Health
      Reuters_Health

      Brazilian health regulator Anvisa has canceled a request for emergency use authorization for the COVID-19 vaccine developed by China's CanSino Biologics Inc (https://t.co/7o9q8rqO24) after the laboratory cut ties with its Brazilian representative. https://t.co/SWMXMIvmF2

Load More